BRIEF published on 11/17/2025 at 09:10, 9 months 24 days ago The Platform Group AG's Ambitious Vision for 2030 Revenue Growth First Berlin Equity Research The Platform Group AG AEBITDA Margin 2030 Vision
PRESS RELEASE published on 11/17/2025 at 09:05, 9 months 24 days ago Original-Research: The Platform Group AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates recommendation on The Platform Group AG to Buy with a target price of €20 by 2030. Detailed analysis on company's long-term goals and revenue growth strategy Revenue Growth First Berlin Equity Research Buy Recommendation The Platform Group AG 2030 Vision
BRIEF published on 11/14/2025 at 09:40, 9 months 27 days ago Platform Group AG vise la croissance avec sa Vision 2030 Rentabilité Stratégie De Croissance The Platform Group AG Évaluation Des Actions Vision 2030
BRIEF published on 11/14/2025 at 09:40, 9 months 27 days ago The Platform Group AG Targets Growth with Vision 2030 Growth Strategy Profitability Stock Valuation The Platform Group AG Vision 2030
PRESS RELEASE published on 11/14/2025 at 09:35, 9 months 27 days ago Original-Research: The Platform Group AG (von NuWays AG): Buy The Platform Group AG, a German company, announces Vision 2030 goals focusing on KPI improvement and margin expansion. The stock is deemed undervalued with a PT of EUR 21.00 The Platform Group AG Margin Expansion Vision 2030 Undervalued PT EUR 21.00
BRIEF published on 11/12/2025 at 08:20, 9 months 29 days ago Platform Group AG dévoile sa Vision 2030 assortie d'objectifs de croissance ambitieux. Expansion Internationale Croissance Des Revenus Intégration De L'IA Stratégie De Fusions Et Acquisitions Augmentation De La Marge
BRIEF published on 11/12/2025 at 08:20, 9 months 29 days ago The Platform Group AG Unveils Vision 2030 with Ambitious Growth Goals AI Integration Revenue Growth M&A Strategy International Expansion Margin Increase
PRESS RELEASE published on 11/12/2025 at 08:15, 9 months 29 days ago The Platform Group publishes Vision 2030: EUR 3 billion in revenue, significant margin increase, and growth to 40,000 partners The Platform Group AG unveils Vision 2030: EUR 3 billion revenue target, double-digit margins, and expansion to 40,000 partners by 2030 The Platform Group AG Revenue Target Vision 2030 Double-digit Margins Partner Expansion
BRIEF published on 11/10/2025 at 10:34, 10 months 1 day ago The Platform Group AG's Growth Trajectory: A Positive Outlook EBITDA Margin Sales Growth Q3 Results Platform Group AG Consumer Goods
BRIEF published on 11/10/2025 at 10:34, 10 months 1 day ago Trajectoire de croissance de Platform Group AG : des perspectives positives Croissance Des Ventes Marge D'EBITDA Résultats Du Troisième Trimestre Groupe Platform AG Biens De Consommation
Published on 09/11/2026 at 15:00, 7 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 37 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 1 hour 9 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 2 hours 7 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 11 hours 7 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/11/2026 at 14:35, 31 minutes ago EQS-Adhoc: Österreichische Post AG: AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Published on 09/11/2026 at 13:48, 1 hour 18 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 09/11/2026 at 07:00, 8 hours 7 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 8 hours 7 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 19 hours 37 minutes ago Availability of the 2026 Interim Financial Report
